Literature DB >> 29062751

Those who do not remember the past are condemned to repeat it.

Prem S Shekar1, Daniel Rinewalt1.   

Abstract

Transcatheter aortic valve replacement (TAVR) for aortic valve stenosis has rapidly progressed from its initial application in the inoperable or high-risk patients to those determined to be intermediate and low risk. It is our concern this has occurred without adequate knowledge or examination of the long-term durability of TAVR valves and the impact on subsequent aortic valve surgery, should it be required. In this editorial, we provide insight and reflect upon lessons learned from past surgical techniques and their subsequent abandonment.

Entities:  

Keywords:  Transcatheter aortic valve replacement; intermediate risk; long-term; opinion

Year:  2017        PMID: 29062751      PMCID: PMC5639213          DOI: 10.21037/acs.2017.09.17

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  15 in total

1.  Outcome after homograft redo operation in aortic position.

Authors:  Anke Kowert; Ferdinand Vogt; Andres Beiras-Fernandez; Bruno Reichart; Eckehard Kilian
Journal:  Eur J Cardiothorac Surg       Date:  2012-02       Impact factor: 4.191

2.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Authors:  Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock
Journal:  N Engl J Med       Date:  2010-09-22       Impact factor: 91.245

3.  Stentless aortic valve reoperations: a surgical challenge.

Authors:  Michael A Borger; Kriengchai Prasongsukarn; Susan Armstrong; Christopher M Feindel; Tirone E David
Journal:  Ann Thorac Surg       Date:  2007-09       Impact factor: 4.330

4.  Aortic valve replacement with stentless and stented porcine valves: a case-match study.

Authors:  T E David; R Puschmann; J Ivanov; J Bos; S Armstrong; C M Feindel; H E Scully
Journal:  J Thorac Cardiovasc Surg       Date:  1998-08       Impact factor: 5.209

5.  Hemodynamic benefits of the Toronto Stentless Valve.

Authors:  D F Del Rizzo; B S Goldman; G T Christakis; T E David
Journal:  J Thorac Cardiovasc Surg       Date:  1996-12       Impact factor: 5.209

Review 6.  Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge.

Authors:  Stamatios Lerakis; Salim S Hayek; Pamela S Douglas
Journal:  Circulation       Date:  2013-01-22       Impact factor: 29.690

7.  Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement.

Authors:  X Y Jin; Z M Zhang; D G Gibson; M H Yacoub; J R Pepper
Journal:  Ann Thorac Surg       Date:  1996-09       Impact factor: 4.330

8.  The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements.

Authors:  M F O'Brien; S Harrocks; E G Stafford; M A Gardner; P G Pohlner; P J Tesar; F Stephens
Journal:  J Heart Valve Dis       Date:  2001-05

9.  Aortic allograft valve reoperation: surgical challenges and patient risks.

Authors:  Edward R Nowicki; Gösta B Pettersson; Nicholas G Smedira; Eric E Roselli; Eugene H Blackstone; Bruce W Lytle
Journal:  Ann Thorac Surg       Date:  2008-09       Impact factor: 4.330

10.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

Authors:  Martin B Leon; Craig R Smith; Michael J Mack; Raj R Makkar; Lars G Svensson; Susheel K Kodali; Vinod H Thourani; E Murat Tuzcu; D Craig Miller; Howard C Herrmann; Darshan Doshi; David J Cohen; Augusto D Pichard; Samir Kapadia; Todd Dewey; Vasilis Babaliaros; Wilson Y Szeto; Mathew R Williams; Dean Kereiakes; Alan Zajarias; Kevin L Greason; Brian K Whisenant; Robert W Hodson; Jeffrey W Moses; Alfredo Trento; David L Brown; William F Fearon; Philippe Pibarot; Rebecca T Hahn; Wael A Jaber; William N Anderson; Maria C Alu; John G Webb
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.